Global Markets for Vascular Closure Devices

Published January 2011 | 103 Pages | 53 Exhibits | Forecasts Through 2015

Subscribe Now

Request Info

Order individually or subscribe and get a complete intel platform.

Buy This Report

Subscribe To All Reports

Overview

The global market for vascular closure devices, analyzed in a new report by Life Science Intelligence, will be influenced by a mix of opposing forces through 2015, when sales are expected to reach more than $800 million. Traditionally concentrated in the U.S. and Western Europe, these devices, which include implantable technologies and external compression products, have received broad adoption during cardiac catheterization procedures. Despite their ability to replace or augment manual compression, facilitate patient throughput, and simplify care for staff, cost-containment efforts and the growing use of transradial access are expected to limit growth in the global market. This report, which covers the U.S., European, and Rest-of-the-World Markets from 2008-2015, examines the factors driving and limiting the adoption of these technologies.

Companies Covered

Abbott Vascular
AccessClosure
Advanced Vascular Dynamics
Benrikal Services
Cardiva Medical
Marine Polymer Technologies
Maquet (Getinge Group)
Morris Innovative
Scion Cardio-Vascular
St. Jude Medical
Terumo
TZ Medical
Vascular Solutions

1. EXECUTIVE SUMMARY

1.1 Methods of Vascular Closure: VCDs and Manual Compression 
1.2 The Global Market by Product Type 
1.3 The Global Market by Region 
1.4 Competitive Analysis 

Exhibit 1-1: Global Vascular Closure Procedures by Type, 2008-2015 
Exhibit 1-2: The Global Market Forecast for Vascular Closure Devices by Type from 2008-2015 
Exhibit 1-3: The Global Market Forecast for Vascular Closure Devices by Region from 2008-2015 
Exhibit 1-4: Global Supplier Shares in 2009 and 2010 

2. OVERVIEW

2.1 The Circulatory System 
2.2 Vascular Anatomy and Physiology 
	2.2.1 Peripheral Arteries 
	2.2.2 Coronary Arteries 
	2.2.3 Arteries of the Head and Neck 
2.3 Vessel Tissues and Structures 
2.4 The Wound Healing Process 
	2.4.1 The Inflammatory Phase 
	2.4.2 Proliferative Phase 
	2.4.3 Remodeling Phase 
	2.4.4 Factors Affecting Vascular Closure 
2.5 Conditions Necessitating Vascular Access 
2.6 Procedural Economics 
	2.6.1 Costs 
	2.6.2 Reimbursement
		2.6.2.1 Revenue Codes 
		2.6.2.2 DRG Codes 
		2.6.2.3 Reimbursement for Diagnostic Procedures 
		2.6.2.4 Economic Justification for Vascular Closure Technologies 

Exhibit 2-1: Overview of the Circulatory System 
Exhibit 2-2: Major Arteries in the Cardiovascular System 
Exhibit 2-3: Types and Functions of the Blood Vessels 
Exhibit 2-4: Peripheral Arteries and Arteries of the Lower Extremity 
Exhibit 2-5: Arteries of the Hand, Including the Radial Artery 
Exhibit 2-6: Arteries of the Head and Neck 
Exhibit 2-7: Anatomy of the Arteries and Veins 
Exhibit 2-8: The Process of Healing Vessel Wounds 
Exhibit 2-9: Cardiovascular Pathologies Necessitating Vascular Access 
Exhibit 2-10: Direct Facility Costs for Diagnostic and Interventional Procedures 
Exhibit 2-11: Average Medicare Reimbursements in 2011 for Common Catheterization Procedures 

3. VASCULAR CLOSURE METHODS AND DEVICES

3.1 Manual Compression 
3.2 Vascular Closure Devices 
	3.2.1 Implantable Devices 
	3.2.2 External Compression Products 
	3.2.3 Companies and Products 


Exhibit 3-1: Methods of Vascular Closure 
Exhibit 3-2: Types of Vascular Closure Devices 
Exhibit 3-3: Clinical Studies Examining Vascular Closure Devices 
Exhibit 3-4: Selected Vascular Closure Devices in 2011 
Exhibit 3-5: Abbott Vascular's Vascular Closure Devices 
Exhibit 3-6: AccessClosure's Mynx Vascular Closure Device 
Exhibit 3-7: Advanced Vascular Dynamics, Selected Vascular Closure Devices 
Exhibit 3-8: Cardiva Medical's Catalyst III 
Exhibit 3-9: Morris Innovative's FISH Device - Procedural Description 
Exhibit 3-10: St. Jude Medical's Angio-Seal STS Plus and VIP Vascular Closure Devices 
Exhibit 3-11:  Scion Cardio-Vascular's Clo-Sur PLUS P.A.D. 
Exhibit 3-12:  Terumo's TR Band 
Exhibit 3-13:  TZ Medical's Neptune and Neptune Plus 
Exhibit 3-14:  Vascular Solutions' D-Stat 

4. PROCEDURE FORECASTS AND MARKET ANALYSIS

4.1 The Global Market Forecast for Vascular Closure Devices 
4.2 The Market by Region 
	4.2.1 The United States 
	4.2.2 Europe 
	4.2.3 Asia-Pacific and the Rest-of-the-World 
	4.2.4 Global Supplier Shares 

Exhibit 4-1: Global Vascular Closure Procedures by Type, 2008-2015 
Exhibit 4-2: The Global Market Forecast for Vascular Closure Devices from 2008-2015 
Exhibit 4-3: The Global Market Forecast for Vascular Closure Devices by Type from 2008-2015 
Exhibit 4-4: The Global Market Forecast for Vascular Closure Devices by Method of Access from 2008-2015 
Exhibit 4-5: The Global Market Forecast for Vascular Closure Devices by Region from 2008-2015 
Exhibit 4-6: U.S. Cardiac Catheterization Procedures by Arterial Access, 2008-2015   
Exhibit 4-7: Cardiac Catheterizations by Type in the U.S., 2008-2015 
Exhibit 4-8: Vascular Closure Procedures by Type in the U.S., 2008-2015 
Exhibit 4-9: The U.S. Market Forecast for Vascular Closure Devices from 2008-2015   
Exhibit 4-10: The U.S. Market Forecast for Vascular Closure Devices by Type from 2008-2015 
Exhibit 4-11: The U.S. Market Forecast for Vascular Closure Devices by Method of Access from 2008-2015 
Exhibit 4-12: European Cardiac Catheterization Procedures by Arterial Access, 2008-2015 
Exhibit 4-13:  Cardiac Catheterizations by Type in Europe, 2008-2015 
Exhibit 4-14:  Vascular Closure Procedures by Type in Europe, 2008-2015 
Exhibit 4-15: The Market Forecast for Vascular Closure Devices in Europe from 2008-2015  
Exhibit 4-16: The Market Forecast for Vascular Closure Devices in Europe by Type from 2008-2015 
Exhibit 4-17: The European Market Forecast for Vascular Closure Devices by Method of Access from 2008-2015 
Exhibit 4-18: AP & ROW Cardiac Catheterization Procedures by Arterial Access, 2008-2015 
Exhibit 4-19:  AP & ROW Cardiac Catheterizations by Type, 2008-2015 
Exhibit 4-20:  AP & ROW Vascular Closure Procedures by Type, 2008-2015 
Exhibit 4-21:  AP & ROW Market Forecast, Vascular Closure Devices,2008-2015 
Exhibit 4-22:  AP & ROW Market Forecast, VCDs by Type, 2008-2015 
Exhibit 4-23: The Market Forecast for Vascular Closure Devices by Method of Access in AP & ROW Countries from 2008-2015 
Exhibit 4-24:  Global Supplier Shares in 2009 and 2010 

5. COMPANY PROFILES

5.1 Abbott Vascular 
5.2 Advanced Vascular Dynamics 
5.3 AccessClosure 
5.4 Benrikal Services 
5.5 Cardiva Medical 
5.6 Marine Polymer Technologies 
5.7 Morris Innovative 
5.8 Scion Cardio-Vascular 
5.9 St. Jude Medical 
5.10 Terumo 
5.11 TZ Medical 
5.12 Vascular Solutions

Ready to get started?

We help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.